Moraxella nonliquefaciens septic arthritis in a hematopoietic stem cell transplant patient a case report and review of the literature
| dc.contributor.author | Khalife, Mohamad Jawad | |
| dc.contributor.author | Merashli, Mira | |
| dc.contributor.author | Kanj, Souha S. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Division of Infectious Diseases | |
| dc.contributor.department | Division of Allergy, Immunology and Rheumatology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:55:17Z | |
| dc.date.available | 2025-01-24T11:55:17Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Background: Septic arthritis is a common rheumatologic condition with myriad microbiological causative agents. Moraxella is one of the very rare causes of septic arthritis. We hereby present the third case of Moraxella nonliquefaciens septic arthritis and the first case in a hematopoietic stem cell transplant patient (HSCT) along with a brief review of the literature. Methods: We used PubMed with google search engine to search the literature for reported cases of moraxella septic arthritis. Results: Information on 19 other cases of moraxella infectious arthritis was found. M. catarrhalis was the most common species isolated. Only 2 reports on M. nonliquefaciens were found; the first one in a multiple myeloma patient and the second one in a diabetic patient on hemodialysis. Predisposing conditions included inflammatory arthritis, prosthetic joints, diabetes, Human Immunodeficiency Virus (HIV) infection, Hepatitis C, hemodialysis, esophageal cancer, valve replacements, alcoholism and Intravenous (IV) drug use. The age group of the reported cases ranged from 3 months to 78 years. Conclusion: Infectious arthritis with Moraxella spp. is a very rare entity which can occur in any age group and in the setting of various underlying medical conditions. © 2019 The Authors | |
| dc.identifier.doi | https://doi.org/10.1016/j.jiph.2019.01.059 | |
| dc.identifier.eid | 2-s2.0-85060725555 | |
| dc.identifier.pmid | 30711347 | |
| dc.identifier.uri | http://hdl.handle.net/10938/31198 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Ltd | |
| dc.relation.ispartof | Journal of Infection and Public Health | |
| dc.source | Scopus | |
| dc.subject | Hematopoietic stem cell transplant | |
| dc.subject | Moraxella nonliquefaciens | |
| dc.subject | Septic arthritis | |
| dc.subject | Administration, oral | |
| dc.subject | Adult | |
| dc.subject | Anti-bacterial agents | |
| dc.subject | Arthritis, infectious | |
| dc.subject | Diagnosis, differential | |
| dc.subject | Elbow joint | |
| dc.subject | Hematopoietic stem cell transplantation | |
| dc.subject | Humans | |
| dc.subject | Lymphoma, t-cell | |
| dc.subject | Male | |
| dc.subject | Moraxella | |
| dc.subject | Moraxellaceae infections | |
| dc.subject | Moxifloxacin | |
| dc.subject | Postoperative complications | |
| dc.subject | Cyclophosphamide | |
| dc.subject | Doxorubicin | |
| dc.subject | Doxycycline | |
| dc.subject | Methotrexate | |
| dc.subject | Prednisolone | |
| dc.subject | Prednisone | |
| dc.subject | Rituximab | |
| dc.subject | Uric acid | |
| dc.subject | Valaciclovir | |
| dc.subject | Vincristine | |
| dc.subject | Antiinfective agent | |
| dc.subject | Alcoholism | |
| dc.subject | Arthrocentesis | |
| dc.subject | Bacterial arthritis | |
| dc.subject | Bacterial growth | |
| dc.subject | Bk virus | |
| dc.subject | Bk virus infection | |
| dc.subject | Blood cell count | |
| dc.subject | Bone marrow | |
| dc.subject | Bone marrow biopsy | |
| dc.subject | Cancer radiotherapy | |
| dc.subject | Case report | |
| dc.subject | Clinical article | |
| dc.subject | Clinical evaluation | |
| dc.subject | Cytomegalovirus infection | |
| dc.subject | Diabetic patient | |
| dc.subject | Drug use | |
| dc.subject | Epstein barr virus | |
| dc.subject | Epstein barr virus infection | |
| dc.subject | Erythema | |
| dc.subject | Erythrocyte sedimentation rate | |
| dc.subject | Esophagus cancer | |
| dc.subject | Fever | |
| dc.subject | Gram staining | |
| dc.subject | Heart valve replacement | |
| dc.subject | Hemodialysis | |
| dc.subject | Hepatitis c | |
| dc.subject | Human | |
| dc.subject | Human immunodeficiency virus | |
| dc.subject | Human immunodeficiency virus infection | |
| dc.subject | Infection prevention | |
| dc.subject | Knee pain | |
| dc.subject | Leukocyte | |
| dc.subject | Leukocyte count | |
| dc.subject | Matched related donor | |
| dc.subject | Medical history | |
| dc.subject | Medline | |
| dc.subject | Mixed infection | |
| dc.subject | Moraxella catarrhalis | |
| dc.subject | Moraxellaceae infection | |
| dc.subject | Multiple myeloma | |
| dc.subject | Outcome assessment | |
| dc.subject | Peripheral t cell lymphoma | |
| dc.subject | Physical examination | |
| dc.subject | Priority journal | |
| dc.subject | Pronation | |
| dc.subject | Range of motion | |
| dc.subject | Relapse | |
| dc.subject | Review | |
| dc.subject | Rheumatology | |
| dc.subject | Search engine | |
| dc.subject | Swelling | |
| dc.subject | Synovial fluid | |
| dc.subject | Time to treatment | |
| dc.subject | Treatment indication | |
| dc.subject | Virus reactivation | |
| dc.subject | Vital sign | |
| dc.subject | X ray | |
| dc.subject | Differential diagnosis | |
| dc.subject | Elbow | |
| dc.subject | Infectious arthritis | |
| dc.subject | Isolation and purification | |
| dc.subject | Microbiology | |
| dc.subject | Oral drug administration | |
| dc.subject | Postoperative complication | |
| dc.subject | T cell lymphoma | |
| dc.title | Moraxella nonliquefaciens septic arthritis in a hematopoietic stem cell transplant patient a case report and review of the literature | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1